Blood Test That Can Warn of Lung Cancer Five Years Early

Telegram Group Join Now

Relevance: GS Paper III (Science & Technology, Health) & GS Paper II (Health Governance)

Source:The Hindu

1 · What Happened

Lung cancer is one of the deadliest cancers in the world. Its greatest danger is that it stays silent in the early stages. By the time a person notices symptoms, the disease has usually spread too far to be treated easily.

A new study, published in the well-known journal Cell and led by Charles Swanton at the Francis Crick Institute, London, offers real hope. It shows that a simple blood test can warn of lung cancer about five years before it actually appears — giving patients a precious head start.

2 · How the Test Works

Our blood carries thousands of tiny proteins released by the body’s organs. Together, these proteins act like a health report card flowing through our blood. By reading them, doctors can sense trouble in an organ without any surgery — using only a blood sample. This approach is called a “liquid biopsy”: checking for disease through blood rather than through body tissue.

The Test in Three Simple Steps

1	A blood sample is taken. An ordinary blood draw — no surgery is needed.

2	A computer studies the proteins. Trained on the health records of tens of thousands of people, the computer compares healthy and cancer patterns to find a special group of 14 proteins linked to future cancer.

3	An early warning is given. The test can signal danger about 5 years in advance and correctly identifies more than three out of four future cases — even in people who never smoked.

An Important Insight: How Lung Cancer “Wakes Up”

The study shares a surprising finding. Air pollution — made of tiny particles called PM2.5 — may not directly damage our genes. Instead, it causes inflammation (irritation and swelling) inside the lungs. This inflammation acts like an alarm clock that can “wake up” faulty cells already present from smoking or old age, and turn them into active cancer. The 14-protein signal is essentially a sign of this hidden inflammation.

A possible medicine: An earlier trial tested a drug called Canakinumab, which reduces inflammation. People who took it had about half as many lung cancers. However, it is very expensive, can have side effects, and is not yet available in India.
The data is mostly Western: The 14-protein signal was discovered mainly from British and American populations. Indian bodies and pollution levels differ, so the test must be checked again for Indians.
Why India needs this: Millions of Indians breathe highly polluted air, so an early-warning test could be especially life-saving here.

3. The Way Ahead for India

Test it on Indians: The Indian Council of Medical Research (ICMR) should conduct large studies to adapt this test to India’s diverse population.
Make treatment affordable: Indian pharmaceutical companies should develop low-cost and safer versions of such medicines, so that an early warning can be matched with a treatment people can actually afford.

UPSC Value Box

Liquid Biopsy	Detecting disease through a blood sample instead of removing body tissue.
Proteomics	The study of the thousands of proteins circulating in our blood.
14-Protein Signature	A group of 14 proteins that together warn of lung cancer about 5 years early.
PM2.5	Very tiny pollution particles that enter the lungs and cause inflammation.
Inflammation	The body’s irritation/swelling response; here it can “awaken” damaged cells into cancer.
Canakinumab	An anti-inflammation drug that lowered lung cancer cases by about half; costly, not yet in India.
Biosimilar	A cheaper, near-identical copy of a costly biological medicine.
ICMR	Indian Council of Medical Research — India’s top body for medical research and trials.
Global Burden (WHO)	Lung cancer causes roughly 2.5 million new cases and 1.8 million deaths worldwide each year.

MCQ Practice Question

Q. With reference to the recent “14-protein signature” study on lung cancer, consider the following statements:

A “liquid biopsy” detects disease by studying proteins in a blood sample rather than by removing body tissue.
The study found that fine pollution particles (PM2.5) mainly cause lung cancer by directly mutating the genes of healthy lung cells.
The protein signature could predict future lung cancer even in people who had never smoked.

Which of the statements given above is/are correct?
(a) 1 and 2 only (b) 1 and 3 only (c) 2 and 3 only (d) 1, 2 and 3

Answer: (b) 1 and 3 only

Statement 1 — Correct: A liquid biopsy uses a blood sample (here, its proteins) instead of removing tissue.
Statement 2 — Incorrect (the trap): The study suggests PM2.5 does not directly mutate genes. Instead, it causes inflammation, which “wakes up” cells already damaged by smoking or ageing. The mechanism has been reversed here.
Statement 3 — Correct: The test identified more than three out of four future cases, including in lifelong non-smokers.

Start Yours at Ajmal IAS – with Mentorship StrategyDisciplineClarityResults that Drives Success

Your dream deserves this moment — begin it here.